Therapeutic Catalyst supports academic researchers in early drug discovery, funding target identification, validation and early antibody or small molecule development to advance treatments for adult cancers.
Cancer Research UK's CDD supports the development of novel cancer agents from preclinical stages to early clinical trials with expert resources, not monetary funding.
A Collaborative Pediatric Cancer Research Awards Program supports fellows, investigators, and consortia studying childhood cancers to advance discoveries, safer treatments, and patients’ quality of life.
The Catalyst Program by SARC funds and mentors innovative pilot sarcoma research projects to accelerate scientific progress and impactful discoveries.
Clinical Research Funding Scheme supports investigators conducting cancer trials, translational research and sample collection to improve treatment and patient outcomes.